Literature DB >> 1384985

Prevalence of adult migraine in general practice.

J Winnem.   

Abstract

In 1988 the International Headache Society presented new criteria for the diagnosis of migraine. We used these criteria in a questionnaire to assist in the diagnosis of migraine. The questionnaire was answered by 230 patients in four general practices. We found a migraine prevalence of 11.7%. More than 70% of migraine patients had 12 or more attacks per year, and the length of attack varied between 4 and 24 h in 80% of them. The majority of migraineurs went to bed during the attack and 55% had stayed away from work due to migraine during the last year. The results of this study are in agreement with others. Migraine is an appreciable economic concern due to frequent short absenteeism from work.

Entities:  

Mesh:

Year:  1992        PMID: 1384985     DOI: 10.1046/j.1468-2982.1992.1205300.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  5 in total

1.  The Zurich Study: XXIII. Epidemiology of headache syndromes in the Zurich cohort study of young adults.

Authors:  K R Merikangas; A E Whitaker; H Isler; J Angst
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

2.  Global trends in migraine care: results from the MAZE survey.

Authors:  Jan Lewis Brandes
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

3.  Need for care and perceptions of MIDAS among headache sufferers study.

Authors:  Walter Stewart; Richard Lipton
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

4.  Comparison of validity and reliability of the Migraine disability assessment (MIDAS) versus headache impact test (HIT) in an Iranian population.

Authors:  Abbas Ghorbani; Ahmad Chitsaz
Journal:  Iran J Neurol       Date:  2011

5.  Headache in General Practice: Frequency, Management, and Results of Encounter.

Authors:  Thomas Frese; Henriette Druckrey; Hagen Sandholzer
Journal:  Int Sch Res Notices       Date:  2014-10-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.